Abraham Fisher
- Cellular and Molecular Neuroscience top 0.5%
- Neuroscience and Neuropharmacology Research 44
- Neuropeptides and Animal Physiology 9
- Pharmacology top 0.5%
- Cholinesterase and Neurodegenerative Diseases 26
- Biological Psychiatry top 5%
- Physiology top 2%
- Alzheimer's disease research and treatments 18
- Neurology top 2%
-
- Receptor Mechanisms and Signaling 47
- Nicotinic Acetylcholine Receptors Study 15
- Ion channel regulation and function 7
-
- Memory and Neural Mechanisms 7
Abraham Fisher
102 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 123
- Cellular and Molecular Neuroscience 2.0k
- Pharmacology 1.5k
- Biological Psychiatry 129
- Physiology 1.3k
- Neurology 381
Countries citing papers authored by Abraham Fisher
This map shows the geographic impact of Abraham Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham Fisher more than expected).
Fields of papers citing papers by Abraham Fisher
This network shows the impact of papers produced by Abraham Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham Fisher. The network helps show where Abraham Fisher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Abraham Fisher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 65 | |
| 2 | 2011 | 115 | |
| 3 | 2011 | 35 | |
| 4 | Advances in Alzheimer's and Parkinson's disease : insights, progress, and perspectives | 2008 | 6 |
| 5 | 2003 | 116 | |
| 6 | 2003 | 10 | |
| 7 | 2002 | 60 | |
| 8 | 2001 | 55 | |
| 9 | 2000 | 53 | |
| 10 | 2000 | 65 | |
| 11 | 1999 | 10 | |
| 12 | 1996 | 117 | |
| 13 | 1995 | 31 | |
| 14 | 1995 | 12 | |
| 15 | 1995 | 25 | |
| 16 | 1992 | 4 | |
| 17 | 1989 | 4 | |
| 18 | 1989 | 56 | |
| 19 | Studies on [ 3 H] hemicholinium-3 ([ 3 H]HC-3), [ 3 H] pirenzepine ([ 3 H]PZ) and [ 3 H](-)quinuclidinyl benzilate ([ 3 H](-)QNB) binding with choline and acetylcholine analogues (AF30, AF64, AF64A) | 1986 | 1 |
| 20 | Alzheimer's and Parkinson's diseases : strategies for research and development | 1986 | 49 |
About Abraham Fisher
Abraham Fisher is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology, having authored 107 papers that have together received 4.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (47 papers), Neuroscience and Neuropharmacology Research (44 papers), Cholinesterase and Neurodegenerative Diseases (26 papers), Alzheimer's disease research and treatments (18 papers), Nicotinic Acetylcholine Receptors Study (15 papers), Neuropeptides and Animal Physiology (9 papers), Memory and Neural Mechanisms (7 papers) and Ion channel regulation and function (7 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.0k citations), Pharmacology (1.5k citations) and Biological Psychiatry (129 citations). Abraham Fisher has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Israel Hanin, Zipora Pittel, Eliahu Heldman, Rachel Brandeis, Rachel Haring, Frank M. LaFerla, Antonella Caccamo, David Gurwitz, Charles R. Mantione and Salvatore Oddo. Their work appears in journals such as Journal of Neurochemistry, Brain Research, European Journal of Pharmacology, Annals of the New York Academy of Sciences and Alzheimer s & Dementia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.